Sign in

CIK 0001850270

  • Emerging growth company

PROKIDNEY CORP.

Sign in to watch
Ticker
PROK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
Operating
EIN
981586514
Phone
+1 336-999-7028
Business address
2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
Former names
Social Capital Suvretta Holdings Corp. III
  1. 4 Conversion Director acquired 757,162 shares (conversion)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Planned sale Chief Regulatory Officer sold 16,412 shares at $2.50 ($41,030)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Conversion Chief Legal Officer acquired 81,928 shares (conversion)
  7. 4 Planned sale Chief Regulatory Officer sold 826 shares at $2.50 ($2,065)
  8. 4 Open-market buy 10% owner bought 8,264,462 shares at $2.42 ($19,999,998)
  9. 4 Planned sale Chief Regulatory Officer sold 17,238 shares at $2.82 ($48,616)
  10. 4 Open-market buy Director bought 22,617,909 shares at $2.42 ($54,735,340)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Planned sale Chief Regulatory Officer sold 17,238 shares at $4.08 ($70,386)
  19. 4 Open-market buy 10% owner bought 177,000 shares at an average $1.42 ($251,666)
  20. 4 Planned sale SVP of Regulatory Development sold 17,238 shares at an average $2.51 ($43,343)

Page 3 of 8 · 153 filings